Moderna Says COVID-19 Vax Patent Suit Should Be Tossed

By Hailey Konnath (May 6, 2022, 11:48 PM EDT) -- Moderna Inc. on Friday urged a Delaware federal court to throw out a lawsuit accusing it of infringing the patents of a rival mRNA developer with its COVID-19 vaccine, arguing that the claims should be filed against the federal government, not Moderna.

In a motion to dismiss, Moderna denies infringing patents held by Pennsylvania drug developer Arbutus Biopharma Corp. but adds that, in any event, those claims can only proceed against the government in the Court of Federal Claims. That's because Moderna supplied the vaccine to the U.S. government as part of a national emergency response, it argues.

Under its contract with...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!